Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination
MA Haimei - Clinical and Applied Thrombosis/Hemostasis, 2021 - journals.sagepub.com
MA Haimei
Clinical and Applied Thrombosis/Hemostasis, 2021•journals.sagepub.comSince the outbreak of Covid-19 in December, 2019, scientists worldwide have been
committed to developing COVID-19 vaccines. Only when most people have immunity to
SARS-CoV-2, COVID-19 can reduce even wholly overcome. So far, nine kinds of COVID-19
vaccines have passed the phase III clinical trials and have approved for use. At the same
time, adverse reactions after COVID-19 vaccination have also reported. This paper focuses
on the adverse effects of thrombosis and thrombocytopenia caused by the COVID-19 …
committed to developing COVID-19 vaccines. Only when most people have immunity to
SARS-CoV-2, COVID-19 can reduce even wholly overcome. So far, nine kinds of COVID-19
vaccines have passed the phase III clinical trials and have approved for use. At the same
time, adverse reactions after COVID-19 vaccination have also reported. This paper focuses
on the adverse effects of thrombosis and thrombocytopenia caused by the COVID-19 …
Since the outbreak of Covid-19 in December, 2019, scientists worldwide have been committed to developing COVID-19 vaccines. Only when most people have immunity to SARS-CoV-2, COVID-19 can reduce even wholly overcome. So far, nine kinds of COVID-19 vaccines have passed the phase III clinical trials and have approved for use. At the same time, adverse reactions after COVID-19 vaccination have also reported. This paper focuses on the adverse effects of thrombosis and thrombocytopenia caused by the COVID-19 vaccine, especially the adenovirus-vector vaccine from AstraZeneca and Pfizer, and discusses its mechanism and possible countermeasures.
![](/scholar/images/qa_favicons/sagepub.com.png)